Christopher M. Crane: Thanks to Jack and Ken. Exelon continues to excel at our core competencies. Operating our plants while keeping the lights on at the utilities and managing risk and optimizing our portfolio. We continue making productivity and operational enhancements to drive efficiencies across our business. Our strong balance sheet allows us to invest in our business and find ways to grow. When we screen growth opportunities, we look for value creating investments that are EPS, free cash flow and credit metrics accretive. We will act on those accretive opportunities at both an incremental level and a transformational level, leveraging our skill in markets. Our operating agreement with CENG is a good example as Jack has just outlined, we are investing $16 billion in our business over the planning period mostly in our regulated utilities as Jack stated we’ll result in a rate based growth of 5% to 6%. In conclusion, we faced a number of challenges. Exelon is focused on the fundamentals of our business throughout the growth process, as we continue to add value to our shareholders. And with that Ravi, I guess we’ll open up for questions.
Christopher M. Crane: The only thing I would add, we have continued to grow in the renewable space as Jack said the Wind and Solar. But a long-term large scale business model on a highly subsidized product is something that we watch closely. The only thing I would add, we have continued to grow in the renewable space, with as Jack said, the Wind and Solar, but a long-term large scale business model on a highly subsidized product is something that we watch closely. We have clearly stated that we think that Washington picking winners and losers on subsidies, it is not a long-term plan. So, we will continue to monitor the Federal policy and the State policy as we look at growth potentials in that area.
Christopher M. Crane: This is Chris, I will cover that. We have worked hard over the last couple of years to continue to focus on cost to maintain some of the viability of the smaller units. As we have mentioned our Clinton facility in MISO, the nuclear team has come up with a fairly good plan to put the plant on annual refueling cycles, which keeps it viable for years to come as the market recovers. As one of the newest boiling water reactors, in our fleet and in the country, it’s a well-run plant, which last year had zero-force loss rate and so we are not ready to give up on it, we are continuing to optimize its cost structure, maintaining it safe but also neutral on the balance sheet. As we look at our other smaller ones, being able to bring Gannett into the Exelon cost structure, I think will give us time to continue to look at that, as we understand the policies that are revolving in New York, around capacity and transmission. So, there is nothing on the chopping block right now. It is constant work to look at cost. It's constant work to look at regulatory structure and if it does not improve, we will be talking more about those facilities.
Christopher M. Crane: So that is accurate to aggregate them. We will start to make the adjustments in the organization and achieve, start to achieve the savings after we receive the regulatory approval which is anticipated sometime around March 15th of next year 2014. So the restructuring to garner the savings will happen in 2014 in the long term run rate my anticipation would be 2015.
Christopher M. Crane: So, Julien we have seen a run rate over history of receiving around 90% of our allocated ARR and FTR value. So this year that’s come down about 20% on us. It’s due somewhat to the allocation process and how PJM models the system and allocates ARRs in initial stages of that process. It’s also due to what I would call less than optimal seams, issues and dispatch, between MISO and PJM that are causing congestion issues at the seams and you get substantial congestion issues in the market, PJM can’t collect enough revenue on congestion to payback the ARR and FTR holders. So, it is a relatively new challenge for us. What we see is working with PJM and MISO to improve the seams issues as one of the first and foremost things we can do. We also see as the transmission system itself gets upgraded and starts to handle the capability of new supply. That will help the situation as well, but prudently we have to plan for lower collection until we see those changes occur.
Christopher M. Crane: It’s the complete long run cost savings that we talked about should be achieved by the first of 2015, which includes the CENG cost savings along with the Genco cost savings. If you want to talk about trajectory…
Christopher M. Crane: Yeah, definitely, if you go back to some of our earlier calls on this and Jack has reiterated that the dividend is essentially sized for the regulatory business to handle with the 65% to 70% dividend up to the HoldCo. So, we could maintain what we think is a very competitive dividend within Exelon or paying to the Exelon shareholders while we’re able to use the balance sheet of the competitive business to grow and see that those dollars and free cash flow back into the competitive business.Ali Agha – SunTrust Robinson Humphrey: Thank you very much.
Christopher M. Crane: I would say it's more skewed towards fixed and to the extent there is some variable because of our situation and our lack of growth in that business, there is some benefit there as well.Paul Fremont – Jefferies & Company: And then, with respect to EDF, are you basically obligated under that put option to buy them out and who basically ends up doing the market assessment in that calculation.
Kenneth W. Cornew: Yeah Dan its Ken, I can help with that. We are on the Constellation side continuing to look at vacant positions and attrition and sweeping them and not [fill in] them as we evolve with our transformation in our organization from the Exelon and Constellation merger. So we have been very disciplined about not hiring until we realized the full efficiency of the merger and the capabilities of the organization and you got to keep that in the context of what we are facing in the commercial markets right now. We had a plan that had retail growing at a more aggressive level, we had back that plan down as you could see in the hedge disclosure, and we backed our cost structure down accordingly. So, we also have continued opportunities on the Constellation side and while we finish our systems integration to improve processes, lower our cost on our IT systems. So, I'm very comfortable with half of that $100 million I talked coming from Constellation and even maybe some more. On the Genco side, it's really been about non-labor opportunities. Our pension cost are down with interest rates going up. Our insurance costs are a bit down and our ExGen CAGR was not very high to begin with before we rolled this extra $100 million out. We are around 0.5% already. So, we think it’s well within our capability to achieve that flat CAGR.
Kenneth W. Cornew: Dan, one thing to realize is we don’t want to be chasing as every time market prices go up and down. I would say $2 to $4 right now is conservative and our views are that there is substantial upside probably on the high end of that $2 to $4 or even more in the marketplace. We have beaten our models up, we have gotten some new models to challenge ourselves, we have challenged ourselves with some outside help and everything I see indicates that this upside should be there in the markets fundamentally when the system actually dispatches. When we are going to see it in the marketplace, we don’t know and we have to be prudent about how we manage the business accordingly, but I see, $2 to $4 being probably a conservative number right now, if you are looking at current market prices.
Kenneth W. Cornew: Its under – in the PJM territory, which is what we are really talking about, with this upside Dan, it’s under 1%.
